Medical News Today: Added to chemotherapy, this drug doubles lung cancer survival
Adding immunotherapy to chemotherapy doubled survival in a trial of metastatic nonsquamous non-small cell lung cancer lacking EGFR and ALK mutations.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Lung Cancer Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Health | Immunotherapy | Lung Cancer | Non-Small Cell Lung Cancer